New Clinical Trial Finds Vitamin D Supplements May Help Alleviate Common Thyroid Disorder

A new clinical trial has found that vitamin D supplements may help alleviate Hashimoto’s disease, a common autoimmune disorder in which the thyroid gland is gradually destroyed. Carried out by researchers in Iran, the study investigated the effect of vitamin D on circulating thyroid antibodies and thyroid hormones. After evaluating the results, the researchers found that patients taking the vitamin D exhibited significantly decreased disease activity.

Part of the endocrine system, the thyroid gland produces hormones that coordinate many of the body’s key functions. Hashimoto’s disease often leads to the gland becoming underactive and not producing enough of these hormones. This can result in symptoms such as fatigue, weight gain, increased sensitivity to cold, joint and muscle pain, constipation, a slowed heart rate, and other problems. Some estimates suggest there may be up to 130 million sufferers of Hashimoto’s disease worldwide.

The Iranian study involved a total of 42 women diagnosed with the disorder. After randomly dividing them into two groups, the researchers gave one group a weekly vitamin D dose of 50,000 IU for a period of three months. The other group was given a weekly placebo pill. At the end of the study the researchers found that patients taking the vitamin D had a significant reduction in their serum levels of anti-thyroperoxidase antibodies, the presence of which are commonly associated with Hashimoto’s disease, and thyroid-stimulating hormone, a hormone produced by the pituitary gland, levels of which are normally raised in the condition.

The researchers concluded that vitamin D supplementation can be helpful for alleviating disease activity in Hashimoto’s disease. They also recommended that further studies should be carried out to determine whether the approach can be introduced into clinical practice.

On the verge of a revolution in healthcare

With vitamin D deficiency already known to be a frequent finding in Hashimoto’s disease, the outcome of this clinical trial will inevitably arouse widespread interest in patients suffering from the condition. However, it should be noted that the trial is far from being the only study indicating the role of micronutrients in Hashimoto’s disease. In fact, research now shows there are multiple nutritional factors involved in determining the risk of developing the disorder. Deficiencies of minerals such as selenium are known to increase the risk, for example. Researchers therefore suggest that where selenium intake is low, a daily supplement of 50-100 mcg may be an appropriate strategy for prevention.

Patients with autoimmune thyroid disease are also known to have a high prevalence of vitamin B12 deficiency. Some researchers suggest that vitamin B12 deficiency occurs in up to 55 percent of patients with these disorders. Replenishing the body’s stores of vitamin B12 can therefore help prevent cognitive impairment and other damaging consequences of deficiency in patients.

But for optimum prevention and control of Hashimoto’s disease, a carefully chosen combination of micronutrients will always offer the best chances of success. This principle is central to Dr. Rath’s groundbreaking Cellular Medicine concept and has brought proven results in every disease area it has thus far been applied to. Notably, therefore, some evidence suggests that coupled with a good diet, combining micronutrients such as vitamin B complex, coenzyme Q10, magnesium, omega-3 fatty acids and others can be helpful in managing the condition.

With the publication of the new Iranian study, Hashimoto’s disease seems poised to join the long list of common diseases for which natural therapies are becoming a viable option for patients. As we stand on the verge of this scientific revolution in healthcare, doctors everywhere would be well-advised to take immediate steps to educate themselves about it. For as is often said, if the doctors of today fail to become the nutritionists of tomorrow, the nutritionists of today will surely become the doctors of tomorrow. Vive la révolution!

• Bio
• Latest Posts

Paul Anthony Taylor

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU'”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings.

Prior to joining the Foundation, Paul's background was in the music industry, where he worked as a keyboard player and programmer with artists including Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas, and Primal Scream.

He first became interested in natural health after falling ill with a chronic fatigue syndrome-related disorder in 1991 and subsequently making a full recovery through the use of natural health therapies. After meeting Dr. Rath and Dr. Niedzwiecki at an anti-Codex rally in Berlin in 2002, Paul was inspired to make a life-changing decision to leave the music industry to work for the Foundation and help defend the right of patients worldwide to have free access to natural health approaches.

You can find Paul on Twitter at @paulanthtaylor

Der Executive Director der Dr. Rath Health Foundation ist einer der Koautoren des explosiven Buchs „Die Nazi-Wurzeln der Brüsseler EU“. Paul ist auch unser Experte zum Thema „Codex Alimentarius-Kommission“ und hat Augenzeugenerfahrung als offizieller beobachtender Teilnehmer bei diesen Treffen.

Bevor er seine Arbeit bei der Stiftung antrat war Paul in der Musikindustrie aktiv. Er arbeitete als Keyboard-Spieler und Programmierer mit Künstlern wie Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas und Primal Scream.

Sein Interesse an natürlicher Gesundheit wuchs, als er 1991 an Störungen erkrankte, die aus einem chronischen Erschöpfungssyndrom resultierten. Durch natürliche Gesundheitstherapien wurde er schließlich vollständig geheilt. Ein Treffen 2002 mit Dr. Rath und Dr. Niedzwiecki bei einer Anti-Codex-Demonstration in Berlin inspirierte ihn zu einer lebensverändernden Entscheidung und er verließ die Musikindustrie um für die Stiftung zu arbeiten und das Recht der Patienten zu verteidigen, weltweit freien Zugang zu natürlichen Gesundheitsverfahren zu haben.

Auf Twitter ist Paul unter @paulanthtaylor zu finden.

Latest posts by Paul Anthony Taylor (see all)

• Plummeting Deaths From Heart Disease in United States Reflect Rise in Use of Dietary Supplements - April 12, 2024
• Growing Evidence of the Protective Effect of Vitamin D Against Breast Cancer - April 5, 2024
• Doctors Report Mysterious Worldwide Cancer ‘Epidemic’ - March 29, 2024
• ‘Definitive’ Evidence Linking Vitamin D to Lower Risk of COVID-19 and ICU Admission - March 22, 2024
• Africa’s Latest Cholera Outbreaks: As Vaccine Stocks Run Out, It’s Time To Consider Alternatives - March 1, 2024